v3.25.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Number and Weighted Average Exercise Price of Options Issued and Outstanding under all Stock Option Plans
The number and weighted-average exercise price of options issued and outstanding under all of the Company’s equity plans are as follows:
Six Months Ended
June 28, 2025
(in millions, except for weighted-average exercise prices)
SharesWeighted-Average
Exercise Price
Options outstanding, beginning of period(1)
1.6 $110.43 
Granted(2)
0.1 165.45 
Canceled(0.1)159.32 
Exercised(0.7)84.80 
Options outstanding, end of period0.9 $119.16 
Options exercisable, end of period0.8 $113.98 
______________
(1)    The Company recorded less than $0.1 million of stock option expenses for discontinued operations for each of the three months ended June 28, 2025 and June 29, 2024. The Company recorded $0.1 million of stock option expenses for discontinued operations for each of the six months ended June 28, 2025 and June 29, 2024.
(2)     No stock options were granted for discontinued operations for the three and six months ended June 28, 2025.
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows:
Six Months Ended
June 28, 2025
(in millions, except for weighted-average grant date fair value amounts)
UnitsWeighted-Average Grant
 Date Fair Value
RSUs outstanding, beginning of period(1)
0.6 $135.96 
Granted(2)
0.2 167.38 
Canceled— 144.77 
Vested(0.1)157.56 
RSUs outstanding, end of period0.7 $142.28 
___________________________
(1)     The Company recorded $1.1 million and $1.2 million of RSU related expense for discontinued operations for each of the three months ended June 28, 2025 and June 29, 2024. The Company recorded $2.3 million and $2.1 million of RSU related expense for discontinued operations for each of the six months ended June 28, 2025 and June 29, 2024.
(2)     No RSUs were granted for discontinued operations for the three and six months ended June 28, 2025.
Schedule of Nonvested Performance-based Units Activity
The number of PSUs outstanding under all of the Company’s equity plans are as follows:
Six Months Ended
June 28, 2025
(in millions, except for weighted-average grant date fair value amounts)UnitsWeighted-Average Grant
 Date Fair Value
PSUs outstanding, beginning of period(1)
0.1 $172.50 
Granted(2)(3)
0.1 181.70 
Canceled(0.1)167.84 
PSUs outstanding, end of period0.1 $181.16 
______________
(1)    The Company recorded $0.3 million of PSU expenses for discontinued operations for each of the three months ended June 28, 2025 and June 29, 2024.     The Company recorded $0.6 million and less than $0.3 million of PSU expenses for discontinued operations for each of the six months ended June 28, 2025 and June 29, 2024.
(2)    On February 25, 2025, the Audit Committee approved the weighted payout percentage of 0% for the 2022 PSU awards (three-year performance period), which were based upon the actual fiscal 2024 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target.
(3)    No PSUs were granted for discontinued operations for the three and six months ended June 28, 2025.
Schedule of Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
Three Months Ended
Six Months Ended
June 28,
2025(1)
June 29,
2024
June 28,
2025(1)
June 29,
2024
Risk-free interest rate
4.0% to 4.2%
—%
4.0% to 4.2%
4.2%
Expected term (in years)5.85.85.9
Estimated volatility
41.0% to 43.1%
—%
41.0% to 43.1%
42.6%
Expected dividends—%—%—%—%
Weighted-average fair value of options granted
$69.61 to $78.81
$—
$69.61 to $78.81
$59.60
______________
(1)     Less than 0.1 million of stock options were granted during the three and six months ended June 28, 2025.